The mechanisms underlying the anti-inflammatory actions of TRPA1 in colitis can be explained by decreasing proinflammatory SP, NKA, NKB and NK1 receptor expression, as well as inhibiting the synthesis of inflammatory cytokines and chemokines presumably derived from macrophages. The gene discussed is TAC1; the disease is colitis.